<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010030492">1</key>
      </foreign-keys>
      <ref-type name="Book Section">5</ref-type>
      <work-type>OS CH : Chapitres d'ouvrages scientifiques</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Frances, Y.</style>
          </author>
        </authors>
        <secondary-authors>
          <author>
            <style face="normal" font="default" size="100%">Fleurentin, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Pelt, J.M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Mazars, G.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Lejosne, J.C.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Cabalion, Pierre</style>
          </author>
        </secondary-authors>
      </contributors>
      <titles>
        <title>Dossier franco-chnois : réglementation des médicaments à base de plante, en France et en Chine : 2. La demande d'autorisation de mise sur le marché d'un nouveau médicament (France et communauté européenne) = Franco-Chinese dossier : regulations on plant-based medical products in France and China : 2. Authorisation request for placing on the market a new medecine (France and European community)</title>
        <secondary-title>Des sources du savoir aux médicaments du futur : actes du 4e congrès européen d'ethnopharmacologie = From the sources of knowledge to the medicines of the future = proceedings of the 4th European Congress on Ethnopharmocology</secondary-title>
        <secondary-title>Congrès Européen d'Ethnopharmacologie</secondary-title>
      </titles>
      <pages>225-229;234-238</pages>
      <keywords>
        <keyword>MEDICAMENT</keyword>
        <keyword>INNOVATION</keyword>
        <keyword>EFFICACITE</keyword>
        <keyword>ESSAI CLINIQUE</keyword>
        <keyword>COMMERCIALISATION</keyword>
        <keyword>REGLEMENTATION</keyword>
        <keyword>AUTORISATION DE MISE SUR LE MARCHE</keyword>
        <keyword>FRANCE</keyword>
        <keyword>EUROPE</keyword>
      </keywords>
      <dates>
        <year>2002</year>
        <pub-dates>
          <date>2000/05/11-13</date>
        </pub-dates>
      </dates>
      <pub-location>Paris (FRA) ; Metz</pub-location>
      <publisher>IRD ; SFE</publisher>
      <call-num>fdi:010030492</call-num>
      <language>FRE</language>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010030492</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers09-03/010030492.pdf</url>
        </pdf-urls>
      </urls>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <custom6>050MEDECI</custom6>
    </record>
  </records>
</xml>
